Consis Medical

Company Overview

Snapshot

Founded in March 2016 by Oleg Popov and Raphael Moisa, Consis Medical operates with 1–10 employees. The company is currently in the Pre-Funding stage. In November 2024, Consis Medical ceased operations.

Business overview

Consis Medical is an early-stage medical device company focused on developing single-use, self-propelled endoscopes. Its core product aims to enable colorectal professionals to perform examinations simply and cost-effectively. The company's technology emphasizes a self-propelling technique designed to be safe, fast, and eliminate the need for anesthesia, serving the healthcare industry, particularly clinics, hospitals, and gastroenterology practices, within the Health Tech & Life Sciences sector.

Strategic signal

Consis Medical ceased operations in November 2024, indicating a significant shift in its business trajectory. This development signals to investors and innovation teams that the company is no longer actively pursuing its mission in the medical device market, despite its prior focus on innovative endoscopy solutions.

Company Intelligence Q&A

What is Consis Medical's primary focus?

Consis Medical is dedicated to the development of single-use, self-propelled endoscopes, aiming to simplify and reduce the cost of colorectal examinations.

When was Consis Medical founded and by whom?

Consis Medical was founded in March 2016 by Oleg Popov and Raphael Moisa.

What is the status of Consis Medical's operations?

Consis Medical ceased to operate in November 2024.

What is the key innovation of Consis Medical's product?

The company's key innovation is a self-propelling technique for endoscopes that is designed to be safe, fast, and does not require anesthesia, while also reducing infection risks and sterilization expenses through a semi-disposable approach.

What was the product stage of Consis Medical's technology?

Consis Medical's product was in the Clinical Trial stage, as reported in March 2018.